BlackRock Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $640K | Sell |
25,334
-9,617
| -28% | -$243K | ﹤0.01% | 2018 |
|
|
2016
Q3 | $864K | Buy |
34,951
+14,223
| +69% | +$352K | ﹤0.01% | 1851 |
|
|
2016
Q2 | $422K | Buy |
20,728
+4,906
| +31% | +$99.9K | ﹤0.01% | 2171 |
|
|
2016
Q1 | $241K | Buy |
15,822
+940
| +6% | +$14.3K | ﹤0.01% | 2423 |
|
|
2015
Q4 | $200K | Sell |
14,882
-7,112
| -32% | -$95.6K | ﹤0.01% | 2534 |
|
|
2015
Q3 | $309K | Buy |
21,994
+330
| +2% | +$4.64K | ﹤0.01% | 2455 |
|
|
2015
Q2 | $368K | Buy |
21,664
+5,652
| +35% | +$96K | ﹤0.01% | 2365 |
|
|
2015
Q1 | $194K | Buy |
16,012
+2,273
| +17% | +$27.5K | ﹤0.01% | 2662 |
|
|
2014
Q4 | $114K | Buy |
13,739
+1,729
| +14% | +$14.3K | ﹤0.01% | 2937 |
|
|
2014
Q3 | $104K | Sell |
12,010
-352
| -3% | -$3.05K | ﹤0.01% | 2946 |
|
|
2014
Q2 | $135K | Buy |
12,362
+1,719
| +16% | +$18.8K | ﹤0.01% | 2851 |
|
|
2014
Q1 | $95K | Buy |
10,643
+2,734
| +35% | +$24.4K | ﹤0.01% | 3028 |
|
|
2013
Q4 | $60K | Buy |
7,909
+938
| +13% | +$7.12K | ﹤0.01% | 3179 |
|
|
2013
Q3 | $51K | Buy |
6,971
+228
| +3% | +$1.67K | ﹤0.01% | 3165 |
|
|
2013
Q2 | $43K | Buy |
+6,743
| New | +$43K | ﹤0.01% | 3190 |
|